K Liu, Y Geng, L Wang, H Xu, M Zou, Y Li… - Molecular …, 2022 - Wiley Online Library
Resistance to gemcitabine is the main challenge of chemotherapy for pancreatic ductal
adenocarcinoma (PDAC). Hence, the development of a response signature to gemcitabine …